KIR3DL2, Human (Lacutamab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-KIR3DL2, Human (Lacutamab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityKIR3DL2, Human (Lacutamab biosimilar)
CloneLacutamab
Host SpeciesRecombinant Mouse
Reactive Specieshuman
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human KIR3DL2 Recombinant Antibody. Tafasitamab, sold under the brand name Monjuvi, is a medication used in combination with lenalidomide for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
Immunogenn/a
Other NamesAnti-KIR3DL2 Recombinant Antibody, Research Grade Lacutamab, Anti-Human KIR3DL2 Recombinant Antibody, IPH4102, Antibody Drug Analogues, Monoclonal Antibody, YR1351, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 2187368-16-5
Catalog #YR1351
Priceplease inquire
Order / More InfoKIR3DL2, Human (Lacutamab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.